Patents by Inventor Ronald Norbert Hermeling

Ronald Norbert Hermeling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6555521
    Abstract: The invention provides individual tetragonal flat rod shaped or plate-like crystals of glucagon-like peptide-1 related molecules, processes for their preparation, compositions and methods of use. The crystal preparations exhibit extended time action in vivo and are useful for treating diabetes, obesity and related conditions.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: April 29, 2003
    Assignee: Eli Lilly and Company
    Inventors: Ronald Norbert Hermeling, James Arthur Hoffmann, Chakravarthy Narasimhan
  • Publication number: 20030045464
    Abstract: The invention provides individual tetragonal flat rod shaped or plate-like crystals of glucagon-like peptide-1 related molecules, processes for their preparation, compositions and methods of use. The crystal preparations exhibit extended time action in vivo and are useful for treating diabetes, obesity and related conditions.
    Type: Application
    Filed: November 30, 2001
    Publication date: March 6, 2003
    Inventors: Ronald Norbert Hermeling, James Arthur Hoffmann, Chakravarthy Narasimhan
  • Patent number: 6380357
    Abstract: The invention provides individual tetragonal flat rod shaped or plate-like crystals of glucagon-like peptide-1 related molecules, processes for their preparation, compositions and methods of use. The crystal preparations exhibit extended time action in vivo and are useful for treating diabetes, obesity and related conditions.
    Type: Grant
    Filed: December 11, 1998
    Date of Patent: April 30, 2002
    Assignee: Eli Lilly and Company
    Inventors: Ronald Norbert Hermeling, James Arthur Hoffmann, Chakravarthy Narasimhan
  • Publication number: 20010014666
    Abstract: The invention provides individual tetragonal flat rod shaped or plate-like crystals of glucagon-like peptide-1 related molecules, processes for their preparation, compositions and methods of use. The crystal preparations exhibit extended time action in vivo and are useful for treating diabetes, obesity and related conditions.
    Type: Application
    Filed: December 11, 1998
    Publication date: August 16, 2001
    Inventors: RONALD NORBERT HERMELING, JAMES ARTHUR HOFFMANN, CHAKAVARTHY NARASIMHAN
  • Patent number: RE41133
    Abstract: The invention provides individual tetragonal flat rod shaped or plate-like crystals of glucagon-like peptide-1 related molecules, processes for their preparation, compositions and methods of use. The crystal preparations exhibit extended time action in vivo and are useful for treating diabetes, obesity and related conditions.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: February 16, 2010
    Assignee: Eli Lilly and Company
    Inventors: Ronald Norbert Hermeling, James Arthur Hoffmann, Chakravarthy N. N. Narasimhan